Status:
ACTIVE_NOT_RECRUITING
Guaranteed Income and Financial Treatment
Lead Sponsor:
Meredith Doherty, PhD, LCSW
Collaborating Sponsors:
Mathematica Policy Research, Inc.
Conditions:
Cancer
Financial Hardship
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if providing advanced cancer patients with $1000/month for 12 months will improve cancer outcomes. The main questions it aims to answer are: To what extent...
Detailed Description
Cancer-related financial hardship (i.e., financial toxicity) has been associated with anxiety and depression, greater pain and symptom burden, treatment nonadherence, and mortality. Out-of-pocket heal...
Eligibility Criteria
Inclusion
- Age = 18 or older
- Newly diagnosed or recurrent advanced cancer (Stage 3 or 4)
- Receiving chemotherapy or immunotherapy (with or without radiation) at one of the recruitment sites
- Within 12 months of receiving systemic therapy and on surveillance at one of the recruitment sites
- ECOG performance status of 1 - 2
- A Pennsylvania Medicaid beneficiary
- A Pennsylvania resident
Exclusion
- Eligible for hospice (i.e. determined by provider to have a prognosis of 6 months or less) at time of randomization
- Unable to communicate in English, Spanish, or Mandarin
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06611982
Start Date
April 1 2023
End Date
July 30 2026
Last Update
July 11 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Pennsylvania Hospital
Philadelphia, New York, United States, 19107
2
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States, 19104
3
Jefferson Health
Philadelphia, Pennsylvania, United States, 19107